Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats

被引:51
作者
Yi, Fan [1 ]
dos Santos, Elisabete A. [1 ]
Xia, Min [1 ]
Chen, Qi-Zheng [1 ]
Li, Pin-Lan [1 ]
Li, Ningjun [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Coll Med, Richmond, VA 23298 USA
关键词
end-stage renal disease; proteinuria; cytoskeleton; glomerulosclerosis; hyperhomocysteinemia;
D O I
10.1159/000101471
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: We previously reported that increase in plasma homocysteine ( Hcys) levels by a 6-week methionine treatment produced remarkable glomerular injury. However, the mechanism by which hyperhomocysteinemia ( hHcys) produces glomerular injury remains unknown. The present study was to observe when glomerular injury happens during hHcys and to explore the possible role of podocyte injury in the progression of glomerulosclerosis associated with hHcys. Methods: Uninephrectomized Sprague-Dawley rats treated with methionine were used to examine the time course of glomerular injury induced by hHcys. Results: Creatinine clearance was not different until rats were treated with methionine for 6 weeks, although plasma Hcys levels significantly increased at the 1st week of methionine treatment. However, urinary albumin excretion increased at the 2nd week of methionine treatment. Morphological examinations showed that mesangial expansion occurred at the 2nd week and podocyte effacement was also observed as processed glomerular damage during hHcys. Immunofluorescence analyses demonstrated that podocin and nephrin expressions were reduced, while alpha-actinin-4 increased during hHcys. Conclusions: Increased plasma Hcys level is an important pathogenic factor resulting in glomerular injury even in the very early time of hHcys. These pathogenic effects of Hcys are associated with podocyte injury and changed expression and distribution of podocyte-associated proteins. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 30 条
[1]   Podocyte injury associated glomerulopathies induced by pamidronate [J].
Barri, YM ;
Munshi, NC ;
Sukumalchantra, S ;
Abulezz, SR ;
Bonsib, SM ;
Wallach, J ;
Walker, PD .
KIDNEY INTERNATIONAL, 2004, 65 (02) :634-641
[2]   NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome [J].
Boute, N ;
Gribouval, O ;
Roselli, S ;
Benessy, F ;
Lee, H ;
Fuchshuber, A ;
Dahan, K ;
Gubler, MC ;
Niaudet, P ;
Antignac, C .
NATURE GENETICS, 2000, 24 (04) :349-354
[3]   Effect of Hyperhomocysteinemia on plasma or tissue adenosine levels and renal function [J].
Chen, YF ;
Li, PL ;
Zou, AP .
CIRCULATION, 2002, 106 (10) :1275-1281
[4]   Hyperhomocysteinemia: detection, risk assessment, and treatment [J].
Dennis, VW ;
Nurko, S ;
Robinson, K .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1997, 6 (05) :483-488
[5]  
Dennis VW, 1996, KIDNEY INT, V50, pS11
[6]  
Ducloux D, 2000, J AM SOC NEPHROL, V11, P134, DOI 10.1681/ASN.V111134
[7]   Podocyte injury and targeting therapy: an update [J].
Durvasula, RV ;
Shankland, SJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2006, 15 (01) :1-7
[8]   NAD(P)H oxidase activity in cultured human podocytes: Effects of adenosine triphosphate [J].
Greiber, S ;
Munzel, T ;
Kastner, S ;
Muller, B ;
Schollmeyer, P ;
Pavenstadt, H .
KIDNEY INTERNATIONAL, 1998, 53 (03) :654-663
[9]   Activation of mesangial cell MAPK in response to homocysteine [J].
Ingram, AJ ;
Krepinsky, JC ;
James, L ;
Austin, RC ;
Tang, DM ;
Salapatek, AM ;
Thai, K ;
Scholey, JW .
KIDNEY INTERNATIONAL, 2004, 66 (02) :733-745
[10]   Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis [J].
Kaplan, JM ;
Kim, SH ;
North, KN ;
Rennke, H ;
Correia, LA ;
Tong, HQ ;
Mathis, BJ ;
Rodríguez-Pérez, JC ;
Allen, PG ;
Beggs, AH ;
Pollak, MR .
NATURE GENETICS, 2000, 24 (03) :251-256